Early Detection Research Network


This biomarker is also known as:
  • lipophilin-C,
  • SCGB2A1,
  • mammaglobin-2,
  • Secretoglobin family 2A member 1,
  • UGB3,
  • secretoglobin, family 2A, member 1,
  • lipophilin C,
  • O75556,
  • mammaglobin B,
  • mammaglobin 2,
  • Mammaglobin-2,
  • MGC71973,
  • Lacryglobin,
  • lacryglobin,
  • mammaglobin-B,
  • MGB2,
  • LPHC,
  • Lipophilin-C,
  • LIPHC,


SCGB2A1, also known as MGB2 or mammaglobin B, encodes a small secreted protein from the secretoglobin family, part of the uterglobin superfamily. SCGB2A1 is normally expressed in the thymus, trachea, kidney, steroid responsive tissues (prostate, testis, uterus, breast and ovary) and salivary gland.


There are no datasets associated with this biomarker.

QA State: Curated
Type: Protein

The following organs have data associated with this biomarker…


Phase: Two
QA State: Under Review


SCGB2A1, also known as MGB2 or mammaglobin B, is highly homologous to mammaglobin A (MGB1), which is overexpressed in breast cancer. SCGB2A1 has also been found to be overexpressed in primary breast cancers. Recently SCGB2A1 was found to be a top differentially expressed gene in ovarian cancer.

Performance Comment

SCGB2A1 was one of 50 tumor vasculature-associated genes with transmembrane or secreted protein products identified through expression profiling of ovarian cancer vascular cells. These 50 tumor vascular markers (TVMs) also had low or no expression in normal tissues. SCGB2A1 was not in the group of 13 selected for further validation.


Phase: One
QA State: Under Review


Performance Comment

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

No associated publications found.